Ocular Therapeutix (OCUL) Revenue (2014 - 2026)

Ocular Therapeutix's Revenue history runs 13 years deep, the most recent figure standing at $10.8 million for Q1 2026.

• In Q1 2026, Revenue rose 0.81% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $52.0 million (down 12.76% YoY), while the FY2025 annual figure was $52.0 million, down 18.47% from the prior year.
• Revenue was $10.8 million for Q1 2026 at Ocular Therapeutix, down from $13.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $17.1 million in Q4 2024 to a low of $10.7 million in Q1 2025.
• Historically, Revenue has averaged $13.9 million across 5 years, with a median of $14.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Revenue surged 79.61% in 2022, then declined 27.59% in 2025.
• A 5-year view of Revenue shows it stood at $14.1 million in 2022, then grew by 5.16% to $14.8 million in 2023, then grew by 15.41% to $17.1 million in 2024, then dropped by 22.43% to $13.2 million in 2025, then slipped by 18.6% to $10.8 million in 2026.
• The last three Revenue figures came in at $10.8 million (Q1 2026), $13.2 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.